Progression of kidney dysfunction in the community-dwelling elderly

被引:301
作者
Hemmelgarn, B. R.
Zhang, J.
Manns, B. J.
Tonelli, M.
Larsen, E.
Ghali, W. A.
Southern, D. A.
McLaughlin, K.
Mortis, G.
Culleton, B. F.
机构
[1] Univ Calgary, Div Nephrol, Foothills Med Ctr, Dept Med, Calgary, AB T2N 2T9, Canada
[2] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada
[3] Inst Hlth Econ, Edmonton, AB, Canada
[4] Univ Alberta, Dept Med, Div Nephrol, Edmonton, AB, Canada
[5] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada
[6] Calgary Lab Serv, Calgary, AB, Canada
[7] Univ Calgary, Ctr Hlth & Policy Studies, Calgary, AB T2N 2T9, Canada
[8] Univ Calgary, Dept Med, Div Gen Internal Med, Calgary, AB T2N 2T9, Canada
关键词
anemia; albuminuria; cardiovascular disease; chronic kidney disease; epdiemiology and outcomes;
D O I
10.1038/sj.ki.5000270
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Despite the high prevalence of chronic kidney disease among the elderly, few studies have described their loss of kidney function. We sought to determine the progression of kidney dysfunction among a community-based cohort of elderly subjects. The cohort included 10 184 subjects 66 years of age or older, who had one or more outpatient serum creatinine measurements during each of two time periods: 1 July to 31 December 2001 and 1 July to 31 December 2003. A mixed effects model, including covariates for age, gender, diabetes mellitus, and comorbidity, was used to determine the rate of decline in estimated glomerular filtration rate (eGFR, in ml/min/1.73m(2)) per year over a median follow-up of 2.0 years. Subjects with diabetes mellitus had the greatest decline in eGFR of 2.1 (95% CI 1.8-2.5) and 2.7 (95% CI 2.3-3.1) ml/min/1.73m 2 per year in women and men, respectively. The rate of decline for women and men without diabetes mellitus was 0.8 (95% CI 0.6-1.0) and 1.4 (95% CI 1.2-1.6) ml/min/1.73m(2) per year. Subjects with a study mean eGFR < 30ml/min/1.73m(2), both those with and without diabetes mellitus, experienced the greatest decline in eGFR. In conclusion, we found that the majority of elderly subjects have no or minimal progression of kidney disease over 2 years. Strategies aimed at slowing progression of kidney disease should consider underlying risk factors for progression and the negligible loss of kidney function that occurs in the majority of older adults.
引用
收藏
页码:2155 / 2161
页数:7
相关论文
共 46 条
[41]   Kidney disease as a risk factor for development of cardiovascular disease - A statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention [J].
Sarnak, MJ ;
Levey, AS ;
Schoolwerth, AC ;
Coresh, J ;
Culleton, B ;
Hamm, LL ;
McCullough, PA ;
Kasiske, BL ;
Kelepouris, E ;
Klag, MJ ;
Parfrey, P ;
Pfeffer, M ;
Raij, L ;
Spinosa, DJ ;
Wilson, PW .
CIRCULATION, 2003, 108 (17) :2154-2169
[42]  
Shlipak Michael G, 2004, Am J Geriatr Cardiol, V13, P81, DOI 10.1111/j.1076-7460.2004.02125.x
[43]   Serum creatinine is an inadequate screening test for renal failure in elderly patients [J].
Swedko, P ;
Clark, HD ;
Paramsothy, K ;
Akbari, A .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (03) :356-360
[44]   Slowing the progression of chronic renal failure: Economic benefits and patients' perspectives [J].
Trivedi, HS ;
Pang, MMH ;
Campbell, A ;
Saab, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (04) :721-729
[45]  
*US REN DAT SYST, 2005, AM J KIDNEY DIS S, V45, pS1
[46]   Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease - Results from the AASK trial [J].
Wright, JT ;
Bakris, G ;
Greene, T ;
Agodoa, LY ;
Appel, LJ ;
Charleston, J ;
Cheek, D ;
Douglas-Baltimore, JG ;
Gassman, J ;
Glassock, R ;
Hebert, L ;
Jamerson, K ;
Lewis, J ;
Phillips, RA ;
Toto, RD ;
Middleton, JP ;
Rostand, SG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (19) :2421-2431